Woodline Partners’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Buy |
518,300
+202,917
| +64% | +$1.46M | 0.02% | 613 |
|
|
2025
Q1 | $2.6M | Buy |
+315,383
| New | +$2.6M | 0.02% | 626 |
|
|
2024
Q4 | – | Sell |
-91,971
| Closed | -$796K | – | 920 |
|
|
2024
Q3 | $796K | Buy |
91,971
+70,723
| +333% | +$612K | 0.01% | 519 |
|
|
2024
Q2 | $186K | Buy |
+21,248
| New | +$186K | ﹤0.01% | 531 |
|